Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash, cash equivalents and restricted cash	$ 973,768	$ 945,587
Short-term investments	17,832	22,689
Accounts receivable, net of allowance of $7,434 and $7,259 at March 31, 2025 and December 31, 2024, respectively	318,233	314,165
Inventory	50,367	44,744
Prepaid expenses and other current assets, net	56,185	48,635
Total current assets	1,416,385	1,375,820
Property and equipment, net	180,453	162,046
Operating lease right-of-use assets	94,631	86,149
Other assets	40,897	36,720
Total assets	1,732,366	1,660,735
Current liabilities:
Accounts payable	39,240	34,922
Accrued compensation	47,086	62,114
Other accrued liabilities	178,449	146,893
Deferred revenue, current portion	20,557	19,754
Short-term debt financing	80,345	80,362
Total current liabilities	365,677	344,045
Deferred revenue, long-term portion and other liabilities	23,958	24,682
Operating lease liabilities, long-term portion	103,056	96,588
Total liabilities	492,691	465,315
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both March 31, 2025 and December 31, 2024; 135,932 and 132,646 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	14	12
Additional paid-in capital	3,874,656	3,763,614
Accumulated deficit	(2,634,798)	(2,567,862)
Accumulated other comprehensive loss	(197)	(344)
Total stockholders' equity	1,239,675	1,195,420
Total liabilities and stockholders' equity	$ 1,732,366	$ 1,660,735